Valganciclovir hydrochloride
175865-59-5
C14H23ClN6O5
390.82
99%
Suitable for treating cytomegalovirus (CMV) retinitis in patients with acquired immunodeficiency syndrome (AIDS). Valganciclovir hydrochloride tablets are suitable for preventing CMV infection in high-risk solid organ transplant patients.
Product details
CAS NO.:175865-59-5
Product Name:Valganciclovir hydrochloride
Synonyms:Valganciclovir hydrochloride;L-VALINE, 2-[(2-AMINO-1,6-DIHYDRO-6-OXO-9H-PURIN-9-YL)METHOXY]-3-HYDROXYPROPYL ESTER, MONOHYDROCHLORIDE;VALGANCICLOVIR HCL;Valganciclovir (hydrochloride);Valganciclovir Hydro;L-Valine (2-[(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy]-3-hydroxypropyl ester;L-Valine,2-[(2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy]-3-hydroxypropyl ester,monohydrochloride (9CI);RS 079070-194;Valcyte;Valcyt;Unii-4p3T9qf9nz;Valganciclovir hydrochlorid;Valganciclovir hydrochloride hydrate;Valganciclovir Hydrochloride (500 mg);194;Ro 107-9070;L-Valine, ester with 9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)guanine, monohydrochloride;L-Valine, 2-((2-amino-1,6-dihydro-6-oxo-9H-purin-9-yl)methoxy)-3-hydroxypropyl ester, monohydrochloride;[2-[(2-amino-6-oxo-3H-purin-9-yl)methoxy]-3-hydroxypropyl] (2S)-2-amino-3-methylbutanoate hydrochloride;Valix
EINECS:
Molecular Formula:C14H23CLN6O5
Molecular Weight:390.8226